GLAXOSMITHKLINE is investing £230million in a US gene profiling company 23andMe, best known for saliva testing kits for people interested in their genetic history.
-»
GSK’s US lab drive
Melbal Directory
14:41
GLAXOSMITHKLINE is investing £230million in a US gene profiling company 23andMe, best known for saliva testing kits for people interested in their genetic history.
-»
 |
 |
 |
 |
 |
Melbal Business news and business directory provides it's readers with the latest business news, articles & opinions on a wide variety of business & finance areas as well as politics. Learn more about Melbal here »
0 Comments